Global Active Pharmaceutical Ingredients (API) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Active Pharmaceutical Ingredients (API) market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Active Pharmaceutical Ingredients (API) market are covered in Chapter 9:
Bristol-Myers Squibb Co.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim Group
Mylan N.V.
AbbVie Inc.
Sanofi S.A.
Aurobindo Pharma Ltd.
Pfizer, Inc.
Dr. Reddy’s Laboratories Ltd.
Merck & Co., Inc.
AstraZeneca plc
Eli Lilly and Company
Lonza Group
Albemarle Corporation
F. Hoffmann-La Roche AG
Cipla Ltd.
Sun Pharmaceutical Industries Ltd.
Novartis AG
GlaxoSmithKline plc
In Chapter 5 and Chapter 7.3, based on types, the Active Pharmaceutical Ingredients (API) market from 2017 to 2027 is primarily split into:
Synthetic APIs
Biotech APIs
In Chapter 6 and Chapter 7.4, based on applications, the Active Pharmaceutical Ingredients (API) market from 2017 to 2027 covers:
Ophthalmology
Nephrology
Gastroenterology
Pulmonology
Endocrinology
Orthopedic
CNS & Neurology
Oncology
Cardiology
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Active Pharmaceutical Ingredients (API) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Active Pharmaceutical Ingredients (API) Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Active Pharmaceutical Ingredients (API) market are covered in Chapter 9:
Bristol-Myers Squibb Co.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim Group
Mylan N.V.
AbbVie Inc.
Sanofi S.A.
Aurobindo Pharma Ltd.
Pfizer, Inc.
Dr. Reddy’s Laboratories Ltd.
Merck & Co., Inc.
AstraZeneca plc
Eli Lilly and Company
Lonza Group
Albemarle Corporation
F. Hoffmann-La Roche AG
Cipla Ltd.
Sun Pharmaceutical Industries Ltd.
Novartis AG
GlaxoSmithKline plc
In Chapter 5 and Chapter 7.3, based on types, the Active Pharmaceutical Ingredients (API) market from 2017 to 2027 is primarily split into:
Synthetic APIs
Biotech APIs
In Chapter 6 and Chapter 7.4, based on applications, the Active Pharmaceutical Ingredients (API) market from 2017 to 2027 covers:
Ophthalmology
Nephrology
Gastroenterology
Pulmonology
Endocrinology
Orthopedic
CNS & Neurology
Oncology
Cardiology
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Active Pharmaceutical Ingredients (API) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Active Pharmaceutical Ingredients (API) Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET OVERVIEW
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API) Market
1.2 Active Pharmaceutical Ingredients (API) Market Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Active Pharmaceutical Ingredients (API) Market Segment by Application
1.3.1 Active Pharmaceutical Ingredients (API) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Active Pharmaceutical Ingredients (API) Market, Region Wise (2017-2027)
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.3 Europe Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.4 China Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.5 Japan Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.6 India Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.8 Latin America Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Active Pharmaceutical Ingredients (API) (2017-2027)
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Active Pharmaceutical Ingredients (API) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Active Pharmaceutical Ingredients (API) Market
2 INDUSTRY OUTLOOK
2.1 Active Pharmaceutical Ingredients (API) Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Active Pharmaceutical Ingredients (API) Market Drivers Analysis
2.4 Active Pharmaceutical Ingredients (API) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Active Pharmaceutical Ingredients (API) Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients (API) Industry Development
3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET LANDSCAPE BY PLAYER
3.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Share by Player (2017-2022)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Player (2017-2022)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Player (2017-2022)
3.4 Global Active Pharmaceutical Ingredients (API) Gross Margin by Player (2017-2022)
3.5 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
3.5.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
3.5.2 Active Pharmaceutical Ingredients (API) Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.5 Europe Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.6 China Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.7 Japan Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.8 India Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.9 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.10 Latin America Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.11 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Under COVID-19
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2017-2022)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2017-2022)
5.4 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Growth Rate of Synthetic APIs (2017-2022)
5.4.2 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Growth Rate of Biotech APIs (2017-2022)
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET ANALYSIS BY APPLICATION
6.1 Global Active Pharmaceutical Ingredients (API) Consumption and Market Share by Application (2017-2022)
6.2 Global Active Pharmaceutical Ingredients (API) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Ophthalmology (2017-2022)
6.3.2 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Nephrology (2017-2022)
6.3.3 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Gastroenterology (2017-2022)
6.3.4 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Pulmonology (2017-2022)
6.3.5 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Endocrinology (2017-2022)
6.3.6 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Orthopedic (2017-2022)
6.3.7 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of CNS & Neurology (2017-2022)
6.3.8 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Oncology (2017-2022)
6.3.9 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Cardiology (2017-2022)
6.3.10 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET FORECAST (2022-2027)
7.1 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2022-2027)
7.2 Global Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate of Synthetic APIs (2022-2027)
7.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate of Biotech APIs (2022-2027)
7.4 Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application (2022-2027)
7.4.1 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Ophthalmology(2022-2027)
7.4.2 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Nephrology(2022-2027)
7.4.3 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Gastroenterology(2022-2027)
7.4.4 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Pulmonology(2022-2027)
7.4.5 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Endocrinology(2022-2027)
7.4.6 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Orthopedic(2022-2027)
7.4.7 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of CNS & Neurology(2022-2027)
7.4.8 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.9 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Cardiology(2022-2027)
7.4.10 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Others(2022-2027)
7.5 Active Pharmaceutical Ingredients (API) Market Forecast Under COVID-19
8 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Active Pharmaceutical Ingredients (API) Analysis
8.6 Major Downstream Buyers of Active Pharmaceutical Ingredients (API) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Active Pharmaceutical Ingredients (API) Industry
9 PLAYERS PROFILES
9.1 Bristol-Myers Squibb Co.
9.1.1 Bristol-Myers Squibb Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.1.3 Bristol-Myers Squibb Co. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Teva Pharmaceutical Industries Ltd.
9.2.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.2.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Boehringer Ingelheim Group
9.3.1 Boehringer Ingelheim Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.3.3 Boehringer Ingelheim Group Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Mylan N.V.
9.4.1 Mylan N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.4.3 Mylan N.V. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AbbVie Inc.
9.5.1 AbbVie Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.5.3 AbbVie Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.6.3 Sanofi S.A. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Aurobindo Pharma Ltd.
9.7.1 Aurobindo Pharma Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.7.3 Aurobindo Pharma Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer, Inc.
9.8.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.8.3 Pfizer, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Dr. Reddy’s Laboratories Ltd.
9.9.1 Dr. Reddy’s Laboratories Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.9.3 Dr. Reddy’s Laboratories Ltd. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Merck & Co., Inc.
9.10.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.10.3 Merck & Co., Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca plc
9.11.1 AstraZeneca plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.11.3 AstraZeneca plc Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Eli Lilly and Company
9.12.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.12.3 Eli Lilly and Company Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Lonza Group
9.13.1 Lonza Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.13.3 Lonza Group Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Albemarle Corporation
9.14.1 Albemarle Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.14.3 Albemarle Corporation Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 F. Hoffmann-La Roche AG
9.15.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.15.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Cipla Ltd.
9.16.1 Cipla Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.16.3 Cipla Ltd. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Sun Pharmaceutical Industries Ltd.
9.17.1 Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.17.3 Sun Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Novartis AG
9.18.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.18.3 Novartis AG Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 GlaxoSmithKline plc
9.19.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.19.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API) Market
1.2 Active Pharmaceutical Ingredients (API) Market Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Active Pharmaceutical Ingredients (API) Market Segment by Application
1.3.1 Active Pharmaceutical Ingredients (API) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Active Pharmaceutical Ingredients (API) Market, Region Wise (2017-2027)
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.3 Europe Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.4 China Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.5 Japan Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.6 India Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.8 Latin America Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Active Pharmaceutical Ingredients (API) (2017-2027)
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Active Pharmaceutical Ingredients (API) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Active Pharmaceutical Ingredients (API) Market
2 INDUSTRY OUTLOOK
2.1 Active Pharmaceutical Ingredients (API) Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Active Pharmaceutical Ingredients (API) Market Drivers Analysis
2.4 Active Pharmaceutical Ingredients (API) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Active Pharmaceutical Ingredients (API) Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients (API) Industry Development
3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET LANDSCAPE BY PLAYER
3.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Share by Player (2017-2022)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Player (2017-2022)
3.3 Global Active Pharmaceutical Ingredients (API) Average Price by Player (2017-2022)
3.4 Global Active Pharmaceutical Ingredients (API) Gross Margin by Player (2017-2022)
3.5 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
3.5.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
3.5.2 Active Pharmaceutical Ingredients (API) Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.5 Europe Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.6 China Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.7 Japan Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.8 India Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.9 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.10 Latin America Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Active Pharmaceutical Ingredients (API) Market Under COVID-19
4.11 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Under COVID-19
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2017-2022)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2017-2022)
5.4 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Growth Rate of Synthetic APIs (2017-2022)
5.4.2 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Growth Rate of Biotech APIs (2017-2022)
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET ANALYSIS BY APPLICATION
6.1 Global Active Pharmaceutical Ingredients (API) Consumption and Market Share by Application (2017-2022)
6.2 Global Active Pharmaceutical Ingredients (API) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Ophthalmology (2017-2022)
6.3.2 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Nephrology (2017-2022)
6.3.3 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Gastroenterology (2017-2022)
6.3.4 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Pulmonology (2017-2022)
6.3.5 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Endocrinology (2017-2022)
6.3.6 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Orthopedic (2017-2022)
6.3.7 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of CNS & Neurology (2017-2022)
6.3.8 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Oncology (2017-2022)
6.3.9 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Cardiology (2017-2022)
6.3.10 Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET FORECAST (2022-2027)
7.1 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2022-2027)
7.2 Global Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate of Synthetic APIs (2022-2027)
7.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Growth Rate of Biotech APIs (2022-2027)
7.4 Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application (2022-2027)
7.4.1 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Ophthalmology(2022-2027)
7.4.2 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Nephrology(2022-2027)
7.4.3 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Gastroenterology(2022-2027)
7.4.4 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Pulmonology(2022-2027)
7.4.5 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Endocrinology(2022-2027)
7.4.6 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Orthopedic(2022-2027)
7.4.7 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of CNS & Neurology(2022-2027)
7.4.8 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.9 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Cardiology(2022-2027)
7.4.10 Global Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate of Others(2022-2027)
7.5 Active Pharmaceutical Ingredients (API) Market Forecast Under COVID-19
8 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Active Pharmaceutical Ingredients (API) Analysis
8.6 Major Downstream Buyers of Active Pharmaceutical Ingredients (API) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Active Pharmaceutical Ingredients (API) Industry
9 PLAYERS PROFILES
9.1 Bristol-Myers Squibb Co.
9.1.1 Bristol-Myers Squibb Co. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.1.3 Bristol-Myers Squibb Co. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Teva Pharmaceutical Industries Ltd.
9.2.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.2.3 Teva Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Boehringer Ingelheim Group
9.3.1 Boehringer Ingelheim Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.3.3 Boehringer Ingelheim Group Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Mylan N.V.
9.4.1 Mylan N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.4.3 Mylan N.V. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AbbVie Inc.
9.5.1 AbbVie Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.5.3 AbbVie Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.6.3 Sanofi S.A. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Aurobindo Pharma Ltd.
9.7.1 Aurobindo Pharma Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.7.3 Aurobindo Pharma Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer, Inc.
9.8.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.8.3 Pfizer, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Dr. Reddy’s Laboratories Ltd.
9.9.1 Dr. Reddy’s Laboratories Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.9.3 Dr. Reddy’s Laboratories Ltd. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Merck & Co., Inc.
9.10.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.10.3 Merck & Co., Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca plc
9.11.1 AstraZeneca plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.11.3 AstraZeneca plc Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Eli Lilly and Company
9.12.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.12.3 Eli Lilly and Company Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Lonza Group
9.13.1 Lonza Group Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.13.3 Lonza Group Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Albemarle Corporation
9.14.1 Albemarle Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.14.3 Albemarle Corporation Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 F. Hoffmann-La Roche AG
9.15.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.15.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Cipla Ltd.
9.16.1 Cipla Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.16.3 Cipla Ltd. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Sun Pharmaceutical Industries Ltd.
9.17.1 Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.17.3 Sun Pharmaceutical Industries Ltd. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Novartis AG
9.18.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.18.3 Novartis AG Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 GlaxoSmithKline plc
9.19.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Active Pharmaceutical Ingredients (API) Product Profiles, Application and Specification
9.19.3 GlaxoSmithKline plc Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Active Pharmaceutical Ingredients (API) Product Picture
Table Global Active Pharmaceutical Ingredients (API) Market Sales Volume and CAGR (%) Comparison by Type
Table Active Pharmaceutical Ingredients (API) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Active Pharmaceutical Ingredients (API) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Active Pharmaceutical Ingredients (API) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients (API) Industry Development
Table Global Active Pharmaceutical Ingredients (API) Sales Volume by Player (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Share by Player (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Share by Player in 2021
Table Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Player (2017-2022)
Table Active Pharmaceutical Ingredients (API) Revenue Market Share by Player (2017-2022)
Table Active Pharmaceutical Ingredients (API) Price by Player (2017-2022)
Table Active Pharmaceutical Ingredients (API) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Active Pharmaceutical Ingredients (API) Sales Volume, Region Wise (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share, Region Wise in 2021
Table Global Active Pharmaceutical Ingredients (API) Revenue (Million USD), Region Wise (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share, Region Wise in 2021
Table Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type in 2021
Table Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2021
Table Active Pharmaceutical Ingredients (API) Price by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate of Synthetic APIs (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Synthetic APIs (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate of Biotech APIs (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Biotech APIs (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption Revenue Market Share by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Ophthalmology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Nephrology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Gastroenterology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Pulmonology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Endocrinology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Orthopedic (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of CNS & Neurology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Oncology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Cardiology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Others (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2022-2027)
Figure USA Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Active Pharmaceutical Ingredients (API) Market Sales Volume Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Price Forecast, by Type
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Synthetic APIs (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Synthetic APIs (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Biotech APIs (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Biotech APIs (2022-2027)
Table Global Active Pharmaceutical Ingredients (API) Market Consumption Forecast, by Application
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast, by Application
Table Global Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) Forecast, by Application
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast, by Application
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Ophthalmology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Nephrology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Gastroenterology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Pulmonology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Endocrinology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Orthopedic (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of CNS & Neurology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Cardiology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Bristol-Myers Squibb Co. Profile
Table Bristol-Myers Squibb Co. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Co. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Co. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Group Profile
Table Boehringer Ingelheim Group Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Group Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Boehringer Ingelheim Group Revenue (Million USD) Market Share 2017-2022
Table Mylan N.V. Profile
Table Mylan N.V. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan N.V. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Mylan N.V. Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc. Profile
Table AbbVie Inc. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure AbbVie Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Aurobindo Pharma Ltd. Profile
Table Aurobindo Pharma Ltd. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aurobindo Pharma Ltd. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Aurobindo Pharma Ltd. Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy’s Laboratories Ltd. Profile
Table Dr. Reddy’s Laboratories Ltd. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy’s Laboratories Ltd. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Dr. Reddy’s Laboratories Ltd. Revenue (Million USD) Market Share 2017-2022
Table Merck &
Figure Active Pharmaceutical Ingredients (API) Product Picture
Table Global Active Pharmaceutical Ingredients (API) Market Sales Volume and CAGR (%) Comparison by Type
Table Active Pharmaceutical Ingredients (API) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Active Pharmaceutical Ingredients (API) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Active Pharmaceutical Ingredients (API) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Active Pharmaceutical Ingredients (API) Industry Development
Table Global Active Pharmaceutical Ingredients (API) Sales Volume by Player (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Share by Player (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Share by Player in 2021
Table Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Player (2017-2022)
Table Active Pharmaceutical Ingredients (API) Revenue Market Share by Player (2017-2022)
Table Active Pharmaceutical Ingredients (API) Price by Player (2017-2022)
Table Active Pharmaceutical Ingredients (API) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Active Pharmaceutical Ingredients (API) Sales Volume, Region Wise (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share, Region Wise in 2021
Table Global Active Pharmaceutical Ingredients (API) Revenue (Million USD), Region Wise (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share, Region Wise (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share, Region Wise in 2021
Table Global Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share by Type in 2021
Table Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) by Type (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2021
Table Active Pharmaceutical Ingredients (API) Price by Type (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate of Synthetic APIs (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Synthetic APIs (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate of Biotech APIs (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Biotech APIs (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption Revenue Market Share by Application (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Ophthalmology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Nephrology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Gastroenterology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Pulmonology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Endocrinology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Orthopedic (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of CNS & Neurology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Oncology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Cardiology (2017-2022)
Table Global Active Pharmaceutical Ingredients (API) Consumption and Growth Rate of Others (2017-2022)
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2022-2027)
Figure USA Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Active Pharmaceutical Ingredients (API) Market Sales Volume Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Market Share Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast, by Type
Table Global Active Pharmaceutical Ingredients (API) Price Forecast, by Type
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Synthetic APIs (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Synthetic APIs (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Biotech APIs (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Revenue (Million USD) and Growth Rate of Biotech APIs (2022-2027)
Table Global Active Pharmaceutical Ingredients (API) Market Consumption Forecast, by Application
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast, by Application
Table Global Active Pharmaceutical Ingredients (API) Market Revenue (Million USD) Forecast, by Application
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast, by Application
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Ophthalmology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Nephrology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Gastroenterology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Pulmonology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Endocrinology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Orthopedic (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of CNS & Neurology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Cardiology (2022-2027)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Bristol-Myers Squibb Co. Profile
Table Bristol-Myers Squibb Co. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Co. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Co. Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Ltd. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Group Profile
Table Boehringer Ingelheim Group Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Group Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Boehringer Ingelheim Group Revenue (Million USD) Market Share 2017-2022
Table Mylan N.V. Profile
Table Mylan N.V. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan N.V. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Mylan N.V. Revenue (Million USD) Market Share 2017-2022
Table AbbVie Inc. Profile
Table AbbVie Inc. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Inc. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure AbbVie Inc. Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table Aurobindo Pharma Ltd. Profile
Table Aurobindo Pharma Ltd. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Aurobindo Pharma Ltd. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Aurobindo Pharma Ltd. Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy’s Laboratories Ltd. Profile
Table Dr. Reddy’s Laboratories Ltd. Active Pharmaceutical Ingredients (API) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy’s Laboratories Ltd. Active Pharmaceutical Ingredients (API) Sales Volume and Growth Rate
Figure Dr. Reddy’s Laboratories Ltd. Revenue (Million USD) Market Share 2017-2022
Table Merck &
